{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:45:33Z","timestamp":1793418333391,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00198-013-2281-1","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T10:24:27Z","timestamp":1362565467000},"page":"2167-2180","source":"Crossref","is-referenced-by-count":79,"title":["Vitamin D and the cardiovascular system"],"prefix":"10.1007","volume":"24","author":[{"given":"L. A.","family":"Beveridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","volume":"78","author":"G Jones","year":"1998","unstructured":"Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193\u20131231","journal-title":"Physiol Rev"},{"key":"2281_CR2","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000151534","volume":"110","author":"G Jean","year":"2008","unstructured":"Jean G, Terrat JC, Vanel T et al (2008) Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6\u00a0months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 110:c58\u2013c65","journal-title":"Nephron Clin Pract"},{"key":"2281_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbrc.2006.08.034","volume":"349","author":"E Gottfried","year":"2006","unstructured":"Gottfried E, Rehli M, Hahn J et al (2006) Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite. Biochem Biophys Res Commun 349:209\u2013213","journal-title":"Biochem Biophys Res Commun"},{"key":"2281_CR4","doi-asserted-by":"crossref","first-page":"491S","DOI":"10.3945\/ajcn.2008.27049","volume":"88","author":"AW Norman","year":"2008","unstructured":"Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491S\u2013499S","journal-title":"Am J Clin Nutr"},{"key":"2281_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","volume":"84","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA, Giovannucci E, Willett WC et al (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18\u201328","journal-title":"Am J Clin Nutr"},{"key":"2281_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.beem.2011.05.010","volume":"25","author":"MR Haussler","year":"2011","unstructured":"Haussler MR, Jurutka PW, Mizwicki M et al (2011) Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25:543\u2013559","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2281_CR7","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80:1689S\u20131696S","journal-title":"Am J Clin Nutr"},{"key":"2281_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M et al (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229\u2013238","journal-title":"J Clin Invest"},{"key":"2281_CR9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","volume":"411","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E et al (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 411:1354\u20131360","journal-title":"Clin Chim Acta"},{"key":"2281_CR10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","volume":"55","author":"JP Forman","year":"2010","unstructured":"Forman JP, Williams JS, Fisher ND (2010) Plasma 25-hydroxyvitamin D and regulation of the renin\u2013angiotensin system in humans. Hypertension 55:1283\u20131288","journal-title":"Hypertension"},{"key":"2281_CR11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","volume":"97","author":"A Vaidya","year":"2012","unstructured":"Vaidya A, Sun B, Larson C et al (2012) Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab 97:2456\u20132465","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","volume":"103","author":"RU Simpson","year":"2007","unstructured":"Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103:521\u2013524","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2281_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.yjmcc.2006.05.019","volume":"41","author":"JJ Green","year":"2006","unstructured":"Green JJ, Robinson DA, Wilson GE et al (2006) Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol 41:350\u2013359","journal-title":"J Mol Cell Cardiol"},{"key":"2281_CR14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.ATV.16.8.978","volume":"16","author":"S Lehto","year":"1996","unstructured":"Lehto S, Niskanen L, Suhonen M et al (1996) Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16:978\u2013983","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2281_CR15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","volume":"96","author":"KE Watson","year":"1997","unstructured":"Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755\u20131760","journal-title":"Circulation"},{"key":"2281_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000159247","volume":"34","author":"N Niederhoffer","year":"1997","unstructured":"Niederhoffer N, Bobryshev YV, Lartaud-Idjouadiene I et al (1997) Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res 34:386\u2013398","journal-title":"J Vasc Res"},{"key":"2281_CR17","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938\u20132948","journal-title":"Circulation"},{"key":"2281_CR18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.00000175571.53833.6c","volume":"97","author":"KA Hruska","year":"2005","unstructured":"Hruska KA, Mathew S, Saab G (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97:105\u2013114","journal-title":"Circ Res"},{"key":"2281_CR19","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","volume":"24","author":"FN Saleh","year":"2003","unstructured":"Saleh FN, Schirmer H, Sundsfjord J et al (2003) Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24:2054\u20132060","journal-title":"Eur Heart J"},{"key":"2281_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(00)00130-9","volume":"47","author":"M Kosch","year":"2000","unstructured":"Kosch M, Hausberg M, Vormbrock K et al (2000) Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 47:813\u2013818","journal-title":"Cardiovasc Res"},{"key":"2281_CR21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","volume":"58","author":"B Kestenbaum","year":"2011","unstructured":"Kestenbaum B, Katz R, de Boer I et al (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58:1433\u20131441","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1159\/000330075","volume":"27","author":"C Molinari","year":"2011","unstructured":"Molinari C, Uberti F, Grossini E et al (2011) 1 Alpha,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27:661\u2013668","journal-title":"Cell Physiol Biochem"},{"key":"2281_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2008.08.020","volume":"204","author":"A Cardus","year":"2009","unstructured":"Cardus A, Panizo S, Encinas M et al (2009) 1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 204:85\u201389","journal-title":"Atherosclerosis"},{"key":"2281_CR24","doi-asserted-by":"crossref","unstructured":"Grundmann M, Haidar M, Placzko S et al (2012) Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol. doi: 10.1152\/ajpcell.00030.2012","DOI":"10.1152\/ajpcell.00030.2012"},{"key":"2281_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000327547","volume":"118","author":"K Stach","year":"2011","unstructured":"Stach K, Kalsch AI, Nguyen XD et al (2011) 1 Alpha,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 118:107\u2013115","journal-title":"Cardiology"},{"key":"2281_CR26","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","volume":"279","author":"K Aihara","year":"2004","unstructured":"Aihara K, Azuma H, Akaike M et al (2004) Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279:35798\u201335802","journal-title":"J Biol Chem"},{"key":"2281_CR27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","volume":"23","author":"D Pitocco","year":"2006","unstructured":"Pitocco D, Crino A, Di Stasio E et al (2006) The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 23:920\u2013923","journal-title":"Diabet Med"},{"key":"2281_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","volume":"57","author":"AM Borissova","year":"2003","unstructured":"Borissova AM, Tankova T, Kirilov G et al (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258\u2013261","journal-title":"Int J Clin Pract"},{"key":"2281_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"AW Norman","year":"1980","unstructured":"Norman AW, Frankel JB, Heldt AM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823\u2013825","journal-title":"Science"},{"key":"2281_CR30","first-page":"E975","volume":"258","author":"GZ Fadda","year":"1990","unstructured":"Fadda GZ, Akmal M, Lipson LG et al (1990) Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol 258:E975\u2013E984","journal-title":"Am J Physiol"},{"key":"2281_CR31","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","volume":"48","author":"H Kolb","year":"2005","unstructured":"Kolb H, Mandrup-Poulsen T (2005) An immune origin of type 2 diabetes? Diabetologia 48:1038\u20131050","journal-title":"Diabetologia"},{"key":"2281_CR32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G et al (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754\u2013759","journal-title":"Am J Clin Nutr"},{"key":"2281_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2249.2005.02961.x","volume":"143","author":"O Equils","year":"2006","unstructured":"Equils O, Naiki Y, Shapiro AM et al (2006) 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol 143:58\u201364","journal-title":"Clin Exp Immunol"},{"key":"2281_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.110.160929","volume":"57","author":"KL Jablonski","year":"2011","unstructured":"Jablonski KL, Chonchol M, Pierce GL (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57:63\u201369","journal-title":"Hypertension"},{"key":"2281_CR35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3945\/ajcn.110.008490","volume":"93","author":"D Reid","year":"2011","unstructured":"Reid D, Toole BJ, Knox S et al (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93:1006\u20131011","journal-title":"Am J Clin Nutr"},{"key":"2281_CR36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","volume":"20","author":"R Scragg","year":"2007","unstructured":"Scragg R, Sowers M, Bell C (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20:713\u2013719","journal-title":"Am J Hypertens"},{"key":"2281_CR37","doi-asserted-by":"crossref","first-page":"e13882","DOI":"10.1371\/journal.pone.0013882","volume":"5","author":"A Fraser","year":"2010","unstructured":"Fraser A, Williams D, Lawlor DA (2010) Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001\u20132006). PLoS One 5:e13882","journal-title":"PLoS One"},{"key":"2281_CR38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159\u20131165","journal-title":"Arch Intern Med"},{"key":"2281_CR39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/db07-1122","volume":"57","author":"E Hypponen","year":"2008","unstructured":"Hypponen E, Boucher BJ, Berry DJ et al (2008) 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45\u00a0years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57:298\u2013305","journal-title":"Diabetes"},{"key":"2281_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3945\/ajcn.111.013516","volume":"94","author":"V Ganji","year":"2011","unstructured":"Ganji V, Zhang X, Shaikh N et al (2011) Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001\u20132006. Am J Clin Nutr 94:225\u2013233","journal-title":"Am J Clin Nutr"},{"key":"2281_CR41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2011.02.051","volume":"58","author":"I Mheid Al","year":"2011","unstructured":"Al Mheid I, Patel R, Murrow J et al (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58:186\u2013192","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR42","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1210\/jc.2010-2212","volume":"96","author":"YF Yiu","year":"2011","unstructured":"Yiu YF, Chan YH, Yiu KH et al (2011) Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 96:E830\u2013E835","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.STR.0000195184.24297.c1","volume":"37","author":"KE Poole","year":"2006","unstructured":"Poole KE, Loveridge N, Barker PJ et al (2006) Reduced vitamin D in acute stroke. Stroke 37:243\u2013245","journal-title":"Stroke"},{"key":"2281_CR44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","volume":"41","author":"A Zittermann","year":"2003","unstructured":"Zittermann A, Schleithoff SS, Tenderich G (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105\u2013112","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ije\/19.3.559","volume":"19","author":"R Scragg","year":"1990","unstructured":"Scragg R, Jackson R, Holdaway IM et al (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19:559\u2013563","journal-title":"Int J Epidemiol"},{"key":"2281_CR46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/diacare.29.03.06.dc05-2148","volume":"29","author":"M Cigolini","year":"2006","unstructured":"Cigolini M, Iagulli MP, Miconi V et al (2006) Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29:722\u2013724","journal-title":"Diabetes Care"},{"key":"2281_CR47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","volume":"49","author":"JP Forman","year":"2007","unstructured":"Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063\u20131069","journal-title":"Hypertension"},{"key":"2281_CR48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/HYPERTENSIONAHA.108.117630","volume":"52","author":"JP Forman","year":"2008","unstructured":"Forman JP, Curhan GC, Taylor EN (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52:828\u2013832","journal-title":"Hypertension"},{"key":"2281_CR49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","volume":"152","author":"AG Pittas","year":"2010","unstructured":"Pittas AG, Chung M, Trikalinos T et al (2010) Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307\u2013314","journal-title":"Ann Intern Med"},{"key":"2281_CR50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/HJH.0b013e32834320f9","volume":"29","author":"A Burgaz","year":"2011","unstructured":"Burgaz A, Orsini N, Larsson SC (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29:636\u2013645","journal-title":"J Hypertens"},{"key":"2281_CR51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/aje\/kwr274","volume":"175","author":"KL Margolis","year":"2012","unstructured":"Margolis KL, Martin LW, Ray RM et al (2012) A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol 175:22\u201332","journal-title":"Am J Epidemiol"},{"key":"2281_CR52","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2337\/dc10-0790","volume":"33","author":"AG Pittas","year":"2010","unstructured":"Pittas AG, Sun Q, Manson JE et al (2010) Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33:2021\u20132023","journal-title":"Diabetes Care"},{"key":"2281_CR53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/dc11-1795","volume":"35","author":"AG Pittas","year":"2012","unstructured":"Pittas AG, Nelson J, Mitri J et al (2012) Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35:565\u2013573","journal-title":"Diabetes Care"},{"key":"2281_CR54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","volume":"65","author":"J Mitri","year":"2011","unstructured":"Mitri J, Muraru MD, Pittas AG (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65:1005\u20131015","journal-title":"Eur J Clin Nutr"},{"key":"2281_CR55","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","volume":"55","author":"NG Forouhi","year":"2012","unstructured":"Forouhi NG, Ye Z, Rickard AP et al (2012) Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 55:2173\u20132182","journal-title":"Diabetologia"},{"key":"2281_CR56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.maturitas.2009.12.013","volume":"65","author":"J Parker","year":"2010","unstructured":"Parker J, Hashmi O, Dutton D et al (2010) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65:225\u2013236","journal-title":"Maturitas"},{"key":"2281_CR57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","volume":"117","author":"TJ Wang","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503\u2013511","journal-title":"Circulation"},{"key":"2281_CR58","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/dc11-1714","volume":"35","author":"GN Thomas","year":"2012","unstructured":"Thomas GN, Hartaigh B, Bosch JA et al (2012) Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care 35:1158\u20131164","journal-title":"Diabetes Care"},{"key":"2281_CR59","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/STROKEAHA.111.636910","volume":"43","author":"Q Sun","year":"2012","unstructured":"Sun Q, Pan A, Hu FB (2012) 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43:1470\u20131477","journal-title":"Stroke"},{"key":"2281_CR60","doi-asserted-by":"crossref","unstructured":"Brondum-Jacobsen P, Nordestgaard BG, Schnohr P et al (2012) 25-Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta-Analysis. Ann Neurol. doi: 10.1002\/ana.23738","DOI":"10.1002\/ana.23738"},{"key":"2281_CR61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10654-012-9729-z","volume":"27","author":"R Chowdhury","year":"2012","unstructured":"Chowdhury R, Stevens S, Ward H et al (2012) Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol 27:581\u2013591","journal-title":"Eur J Epidemiol"},{"key":"2281_CR62","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1161\/ATVBAHA.112.248039","volume":"32","author":"P Brondum-Jacobsen","year":"2012","unstructured":"Brondum-Jacobsen P, Benn M, Jensen GB et al (2012) 25-Hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 32:2794\u20132802","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2281_CR63","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1017\/S1368980011001455","volume":"14","author":"R Scragg","year":"2011","unstructured":"Scragg R (2011) Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr 14:1515\u20131532","journal-title":"Public Health Nutr"},{"key":"2281_CR64","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ypmed.2010.06.013","volume":"51","author":"NC Grandi","year":"2010","unstructured":"Grandi NC, Breitling LP, Brenner H (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51:228\u2013233","journal-title":"Prev Med"},{"key":"2281_CR65","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","volume":"58","author":"S Pilz","year":"2011","unstructured":"Pilz S, Iodice S, Zittermann A (2011) Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58:374\u2013382","journal-title":"Am J Kidney Dis"},{"key":"2281_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCHEARTFAILURE.109.907899","volume":"3","author":"MD Witham","year":"2010","unstructured":"Witham MD, Crighton LJ, Gillespie ND (2010) The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 3:195\u2013201","journal-title":"Circ Heart Fail"},{"key":"2281_CR67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","volume":"103","author":"E Shane","year":"1997","unstructured":"Shane E, Mancini D, Aaronson K et al (1997) Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103:197\u2013207","journal-title":"Am J Med"},{"key":"2281_CR68","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","volume":"93","author":"S Pilz","year":"2008","unstructured":"Pilz S, Marz W, Wellnitz B et al (2008) Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93:3927\u20133935","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR69","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ahj.2010.08.004","volume":"160","author":"RS Boxer","year":"2010","unstructured":"Boxer RS, Kenny AM, Cheruvu VK et al (2010) Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J 160:893\u2013899","journal-title":"Am Heart J"},{"key":"2281_CR70","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","volume":"14","author":"I Gotsman","year":"2012","unstructured":"Gotsman I, Shauer A, Zwas DR et al (2012) Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 14:357\u2013366","journal-title":"Eur J Heart Fail"},{"key":"2281_CR71","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","volume":"106","author":"JL Anderson","year":"2010","unstructured":"Anderson JL, May HT, Horne BD et al (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106:963\u2013968","journal-title":"Am J Cardiol"},{"key":"2281_CR72","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ahj.2011.06.013","volume":"162","author":"M Rienstra","year":"2011","unstructured":"Rienstra M, Cheng S, Larson MG et al (2011) Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J 162:538\u2013541","journal-title":"Am Heart J"},{"key":"2281_CR73","first-page":"A14699","volume":"124","author":"MB Smith","year":"2011","unstructured":"Smith MB, May HT, Blair TL et al (2011) Vitamin D excess is significantly associated with risk of atrial fibrillation. Circulation 124:A14699","journal-title":"Circulation"},{"key":"2281_CR74","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00198-003-1390-7","volume":"14","author":"G Isaia","year":"2003","unstructured":"Isaia G, Giorgino R, Rini GB et al (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14:577\u2013582","journal-title":"Osteoporos Int"},{"key":"2281_CR75","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCRESAHA.109.207019","volume":"105","author":"C Oplander","year":"2009","unstructured":"Oplander C, Volkmar CM, Paunel-Gorgulu A et al (2009) Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 105:1031\u20131040","journal-title":"Circ Res"},{"key":"2281_CR76","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1210\/jc.2012-2126","volume":"97","author":"AD Wood","year":"2012","unstructured":"Wood AD, Secombes KR, Thies F et al (2012) Vitamin D3 supplementation Has no effect on conventional cardiovascular risk factors. a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 97:3557\u20133568","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1373\/clinchem.2011.180562","volume":"58","author":"GD Carter","year":"2012","unstructured":"Carter GD (2012) 25-hydroxyvitamin D: a difficult analyte. Clin Chem 58:486\u2013488","journal-title":"Clin Chem"},{"key":"2281_CR78","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1097\/HJH.0b013e32832f075b","volume":"27","author":"MD Witham","year":"2009","unstructured":"Witham MD, Nadir MA, Struthers AD (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27:1948\u20131954","journal-title":"J Hypertens"},{"key":"2281_CR79","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/SMJ.0b013e3181e6d389","volume":"103","author":"SH Wu","year":"2010","unstructured":"Wu SH, Ho SC, Zhong L et al (2010) Effects of vitamin D supplementation on blood pressure. South Med J 103:729\u2013737","journal-title":"South Med J"},{"key":"2281_CR80","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2012.111","volume":"25","author":"T Larsen","year":"2012","unstructured":"Larsen T, Mose FH, Bech JN (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25:1215\u20131222","journal-title":"Am J Hypertens"},{"key":"2281_CR81","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y et al (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307:674\u2013684","journal-title":"JAMA"},{"key":"2281_CR82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-11-42","volume":"11","author":"H Wang","year":"2012","unstructured":"Wang H, Xia N, Yang Y (2012) Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 11:42","journal-title":"Lipids Health Dis"},{"key":"2281_CR83","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","volume":"99","author":"JL Perez-Castrillon","year":"2007","unstructured":"Perez-Castrillon JL, Vega G, Abad L et al (2007) Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 99:903\u2013905","journal-title":"Am J Cardiol"},{"key":"2281_CR84","doi-asserted-by":"crossref","first-page":"957174","DOI":"10.1155\/2010\/957174","volume":"2010","author":"L Rejnmark","year":"2010","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L (2010) Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol 2010:957174","journal-title":"Int J Endocrinol"},{"key":"2281_CR85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10557-009-6181-8","volume":"23","author":"B Yavuz","year":"2009","unstructured":"Yavuz B, Ertugrul DT, Cil H et al (2009) Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 23:295\u2013299","journal-title":"Cardiovasc Drugs Ther"},{"key":"2281_CR86","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/clpt.2008.165","volume":"85","author":"JB Schwartz","year":"2009","unstructured":"Schwartz JB (2009) Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence. Clin Pharmacol Ther 85:198\u2013203","journal-title":"Clin Pharmacol Ther"},{"key":"2281_CR87","doi-asserted-by":"crossref","unstructured":"Witham MD, Dove FJ, Khan F et al (2012) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction\u2014a randomised controlled trial. Int J Cardiol. doi: 10.1016\/j.ijcard.2012.03.054","DOI":"10.1016\/j.ijcard.2012.03.054"},{"key":"2281_CR88","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00125-010-1838-1","volume":"53","author":"MD Witham","year":"2010","unstructured":"Witham MD, Dove FJ, Dryburgh M et al (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53:2112\u20132119","journal-title":"Diabetologia"},{"key":"2281_CR89","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.numecd.2010.11.001","volume":"22","author":"MD Witham","year":"2012","unstructured":"Witham MD, Dove FJ, Sugden JA et al (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients\u2014a randomised controlled trial. Nutr Metab Cardiovasc Dis 22:864\u2013870","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2281_CR90","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2008-1212","volume":"94","author":"O Tarcin","year":"2009","unstructured":"Tarcin O, Yavuz DG, Ozben B et al (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94:4023\u20134030","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","volume":"25","author":"JA Sugden","year":"2008","unstructured":"Sugden JA, Davies JI, Witham MD et al (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diab Med 25:320\u2013325","journal-title":"Diab Med"},{"key":"2281_CR92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ajh.2011.12","volume":"24","author":"RA Harris","year":"2011","unstructured":"Harris RA, Pedersen-White J, Guo DH et al (2011) Vitamin D3 supplementation for 16\u00a0weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24:557\u2013562","journal-title":"Am J Hypertens"},{"key":"2281_CR93","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","volume":"115","author":"J Hsia","year":"2007","unstructured":"Hsia J, Heiss G, Ren H et al (2007) Calcium\/vitamin D supplementation and cardiovascular events. Circulation 115:846\u2013854","journal-title":"Circulation"},{"key":"2281_CR94","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc07-1829","volume":"31","author":"IH Boer de","year":"2008","unstructured":"de Boer IH, Tinker LF, Connelly S et al (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women\u2019s Health Initiative. Diabetes Care 31:701\u2013707","journal-title":"Diabetes Care"},{"key":"2281_CR95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.326.7387.469","volume":"326","author":"DP Trivedi","year":"2003","unstructured":"Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469","journal-title":"BMJ"},{"key":"2281_CR96","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2011-0398","volume":"96","author":"MB Elamin","year":"2011","unstructured":"Elamin MB, Abu Elnour NO, Elamin KB et al (2011) Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:1931\u20131942","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR97","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-152-5-201003020-00010","volume":"152","author":"L Wang","year":"2010","unstructured":"Wang L, Manson JE, Song Y et al (2010) Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152:315\u2013323","journal-title":"Ann Intern Med"},{"key":"2281_CR98","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/jnci\/djn360","volume":"100","author":"RT Chlebowski","year":"2008","unstructured":"Chlebowski RT, Johnson KC, Kooperberg C et al (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100:1581\u20131591","journal-title":"J Natl Cancer Inst"},{"key":"2281_CR99","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","volume":"27","author":"P Marckmann","year":"2012","unstructured":"Marckmann P, Agerskov H, Thineshkumar S et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523\u20133531","journal-title":"Nephrol Dial Transplant"},{"key":"2281_CR100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","volume":"6","author":"P Kandula","year":"2011","unstructured":"Kandula P, Dobre M, Schold JD et al (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50\u201362","journal-title":"Clin J Am Soc Nephrol"},{"key":"2281_CR101","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","volume":"147","author":"SC Palmer","year":"2007","unstructured":"Palmer SC, McGregor DO, Macaskill P (2007) Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147:840\u2013853","journal-title":"Ann Intern Med"},{"key":"2281_CR102","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D Zeeuw de","year":"2010","unstructured":"de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543\u20131551","journal-title":"Lancet"},{"key":"2281_CR103","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","volume":"7","author":"J Cheng","year":"2012","unstructured":"Cheng J, Zhang W, Zhang X et al (2012) Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol 7:391\u2013400","journal-title":"Clin J Am Soc Nephrol"},{"key":"2281_CR104","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/j.1464-5491.2012.03672.x","volume":"29","author":"PS George","year":"2012","unstructured":"George PS, Pearson ER, Witham MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 29:e142\u2013e150","journal-title":"Diabet Med"},{"key":"2281_CR105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ageing\/afp109","volume":"38","author":"A Avenell","year":"2009","unstructured":"Avenell A, Cook JA, Maclennan GS et al (2009) Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 38:606\u2013609","journal-title":"Age Ageing"},{"key":"2281_CR106","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1023\/A:1014559600042","volume":"17","author":"S Rajasree","year":"2001","unstructured":"Rajasree S, Rajpal K, Kartha CC et al (2001) Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 17:567\u2013571","journal-title":"Eur J Epidemiol"},{"key":"2281_CR107","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2012-1176","volume":"97","author":"D Durup","year":"2012","unstructured":"Durup D, Jorgensen HL, Christensen J (2012) A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 97:2644\u20132652","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR108","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-156-9-201205010-00004","volume":"156","author":"IH Boer de","year":"2012","unstructured":"de Boer IH, Levin G, Robinson-Cohen C et al (2012) Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med 156:627\u2013634","journal-title":"Ann Intern Med"},{"key":"2281_CR109","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691","journal-title":"BMJ"},{"key":"2281_CR110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2011-1309","volume":"97","author":"A Avenell","year":"2012","unstructured":"Avenell A, Maclennan GS, Jenkinson DJ et al (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and\/or calcium (RECORD trial). J Clin Endocrinol Metab 97:614\u2013622","journal-title":"J Clin Endocrinol Metab"},{"key":"2281_CR111","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","volume":"342","author":"MJ Bolland","year":"2011","unstructured":"Bolland MJ, Grey A, Avenell A (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women\u2019s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040","journal-title":"BMJ"},{"key":"2281_CR112","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2011-3328","volume":"97","author":"L Rejnmark","year":"2012","unstructured":"Rejnmark L, Avenell A, Masud T et al (2012) Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 97:2670\u20132681","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2281-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2281-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2281-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:31:54Z","timestamp":1688081514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2281-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":112,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2281-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}